We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Orpea SA | EU:ORP | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -0.08% | 12.484 | 12.45 | 12.484 | 12.61 | 12.372 | 12.40 | 60,481 | 11:50:52 |
EBITDAR 2023 Estimated at Around €690 Million1, -2.8% Below the Forecast of €710 Million Published on 6 November 2023
Regulatory News:
ORPEA (Paris:ORP) (the "Company") reminds that a Third Amendment (the "Amendment" or the "Third Amendment") (link) to the 2022 Universal Registration Document (the "Universal Registration Document" or "URD") was filed on 17 January 2024 under reference number D.23-0461-A03 with the Autorité des marchés financiers. The Third Amendment is part of the prospectus approved on 17 January 2024 by the Autorité des marchés financiers under reference number 24-006 for the purposes of the rights issue in the amount of 390 million euros announced today by the Company.
The Company points out that the Third Amendment includes, in Chapter 4, the Company's estimated financial data for the year ended 31 December 2023. This information was reviewed by the Company's Board of Directors on 16 January 2024, and has not been audited by the Company's statutory auditors. The final consolidated financial statements may therefore differ from these estimated financial data.
Based in particular on an average Group occupancy rate estimated at 83.1% (compared with a forecast of 83.5% set out in the First Amendment to the Universal Registration Document dated 10 November 2023 (the "First Amendment")), on personnel costs, excluding headquarters costs, estimated at 62.2% of sales (compared with a forecast of 61.2% set out in the First Amendment, the Group having experienced a lower occupancy rate than initially forecasted and salary increases in certain countries towards the end of the 2023 financial year), and on headquarters costs estimated at 6.8% of sales (compared with a forecast of 7.1% set out in the First Amendment), the Company estimates that:
The Company also anticipates that, as of the date of this Third Amendment, the following items are likely to have a material impact on the consolidated income statement for the year ended 31 December 2023:
net of miscellaneous expenses related to the financial restructuring incurred during 2023 and/or provisioned at 31 December 2023 (approximately 120 million euros);
With regard to the 2024-2025-2026 financial years, the Company confirms all the outlooks presented in paragraph 5.5.2 of the First Amendment, and in particular the objectives, by 2026, of an EBITDAR margin of 19%, net debt (excluding IFRS adjustments and IFRS 16) reduced to close to 3.6 billion euros, and the ratio of net debt to pre-IFRS 16 EBITDA (financial leverage) at 5.5x.
All these items are based on data, assumptions and estimates considered reasonable by the Group as of today.
The consolidated financial statements prepared in accordance with IFRS rules for the year ended 31 December 2023, which will be the subject of a statutory audit report by the Company's Statutory Auditors, are expected to be released during May 2024 at the latest.
The table below summarizes the estimated financial data for the year ended December 31, 2023 presented above, compared with the forecasts for the year ended December 31, 2023 presented in paragraph 5.5.1 of the First Amendment:
2023 (estimated
financial data as set
out in the Third
Amendment)
2023 (forecast for the
year ending 31
December 2023 as
set out in the First
Amendment)
Gap estimated data
vs forecast
Revenue
c. €5.2 billion
c. €5.2 billion
unchanged
EBITDAR
c. €690 million
c. €710 million
-2.8%
EBITDA pre-IFRS 16
c. €210 million
c. €230 million
-8.7%
Cash position
€639 million
€637 million
+0.3%
General information
The 2022 Universal Registration Document and its amendments are available on the website of the Autorité des marchés financiers (www.amf-france.org) and on the Company's website at www.orpea-group.com/en, under Publications / Universal registration document. They can also be sent by e-mail upon request to the following address: financegroupe@orpea.net and are available free of charge on written request from ORPEA, Service Relations Investisseurs, 12 rue Jean Jaurès - 92800 Puteaux.
DISCLAIMER
This document contains forward-looking statements that involve risks and uncertainties, including those included or incorporated by reference, concerning the Group's future growth and profitability, which could cause actual results to differ materially from those indicated in the forward-looking statements. These risks and uncertainties relate to factors that the Company cannot control or estimate precisely, such as future market conditions. The forward-looking statements contained in this document constitute expectations of future events and should be regarded as such. Actual events or results may differ from those described in this document due to a number of risks or uncertainties described in Chapter 2 of the 2022 Universal Registration Document dated 7 June 2023, as amended in Chapter 2 of the first, second and third amendments to the Company's 2022 Universal Registration Document dated 10 November 2023, 5 December 2023 and 17 January 2024, available on the Company's website and that of the Autorité des marchés financiers (www.amf-france.org).
About ORPEA
ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 20 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), medical and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.
https://www.orpea-group.com/en
Since December 2023, the ORPEA Group has been 50.2% owned by Caisse des Dépôts, CNP Assurances, MAIF and MACSF Epargne Retraite.
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120 and CAC Mid 60 indices.
______________________________ 1 Unaudited figures
View source version on businesswire.com: https://www.businesswire.com/news/home/20240117849605/en/
Investor Relations ORPEA Benoit Lesieur Investor Relations Director b.lesieur@orpea.net
Toll-free number for shareholders : 0 805 480 480
Investor Relations NewCap Dusan Oresansky 01 44 71 94 94 ORPEA@newcap.eu
Press Relations ORPEA Isabelle Herrier-Naufle Press Relations Director 07 70 29 53 74 i.herrier-naufle@orpea.net
Image7 Charlotte Le Barbier // Laurence Heilbronn 06 78 37 27 60 - 06 89 87 61 37 clebarbier@image7.fr lheilbronn@image7.fr
1 Year Orpea Chart |
1 Month Orpea Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions